Literature DB >> 4764347

Enhancement of in vitro lymphocyte response by neuraminidase.

T Han.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4764347      PMCID： PMC1553756     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  10 in total

1.  Fertilization of rabbit ova in vitro by sperm with adsorbed Sendai virus.

Authors:  R J Ericsson; D A Buthala; J F Norland
Journal:  Science       Date:  1971-07-02       Impact factor: 47.728

2.  Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures.

Authors:  G Lundgren; R L Simmons
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

3.  Effect of neuraminidase on serological properties of murine lymphoid cells.

Authors:  M Schlesinger; B D Amos
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

4.  Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase.

Authors:  R L Simmons; A Rios; P K Ray
Journal:  Nat New Biol       Date:  1971-06-09

Review 5.  Biochemical and biophysical properties of cell membranes.

Authors:  E J Ambrose
Journal:  Proc Can Cancer Conf       Date:  1967

6.  Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment.

Authors:  J G Bekesi; G St-Arneault; J F Holland
Journal:  Cancer Res       Date:  1971-12       Impact factor: 12.701

7.  Some effects of neuraminidase on the in vitro interactions between spleen and mastocytoma (P815) cells.

Authors:  L Weiss; T L Cudney
Journal:  Int J Cancer       Date:  1971-03-15       Impact factor: 7.396

8.  An alteration in tumor histocompatibility induced by neuraminidase.

Authors:  B H Sanford
Journal:  Transplantation       Date:  1967-09-05       Impact factor: 4.939

9.  Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG.

Authors:  R L Simmons; A Rios
Journal:  Science       Date:  1971-11-05       Impact factor: 47.728

10.  Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.

Authors:  G A Currie; K D Bagshawe
Journal:  Br J Cancer       Date:  1969-03       Impact factor: 7.640
  10 in total
  9 in total

1.  Galactose oxidase-induced blastogenesis of human lymphocytes and the effect of macrophages on the reaction.

Authors:  M Biniaminov; B Ramot; E Rosenthal; A Novogrodsky
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

2.  Specific effect of neuraminidase on blastogenic response of sensitized lymphocytes.

Authors:  T Han
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

3.  Enhancement of histamine release from human basophils pretreated with different sialidases.

Authors:  C Jensen; B T Dahl; S Norn; P Stahl Skov
Journal:  Agents Actions       Date:  1986-08

4.  Stimulatory effect of Vibrio cholerae neuraminidase on the antibody response to various antigens.

Authors:  J Knop; H H Sedlacek; F R Seiler
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

5.  Enhancement of delayed skin hypersensitivity by neuraminidase in cancer patients.

Authors:  T Han
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

6.  Formation of auto-rosettes by peripheral blood lymphocytes.

Authors:  G P Sandilands; K Gray; A Cooney; J D Browning
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

7.  Interaction of an acute phase reactant, alpha 1-acid glycoprotein (orosomucoid), with the lymphoid cell surface: a model for non-specific immune suppression.

Authors:  D A Cheresh; D H Haynes; J A Distasio
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

8.  Effect of Vibrio cholerae neuraminidase on the phagocytosis of E. coli by macrophages in vivo and in vitro.

Authors:  J Knop; W Ax; H H Sedlacek; F R Seiler
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

9.  Neuraminidase and tumor immunotherapy.

Authors:  H H Sedlacek; F R Seiler; H G Schwick
Journal:  Klin Wochenschr       Date:  1977-03-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.